Sun Pharma Advanced Research reports net loss of Rs 61 crore in Q1

27 Jul 2021 Evaluate

Sun Pharma Advanced Research (SPARC) has reported results for first quarter ended June 30, 2021.

The company has reported net loss at Rs 61.37 crore for the quarter under review as compared to net profit of Rs 56.69 crore for the same quarter in the previous year. Total income of the company decreased by 87.75% at Rs 22.79 crore for Q1FY22 as compared Rs 186.11 crore for the corresponding quarter previous year.

SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

133.75 -0.30 (-0.22%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 654.25
Indegene 522.50
CMS Info Systems 343.20
Sagility 52.23
Smartworks Coworking 472.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×